The makers of Paxil, GlaxoSmithKline, recently updated the warning label on this drug to include the risks of certain birth defects. This update came in the face of a study conducted by GlaxoSmithKline and the FDA that showed an increased risk of birth defects in the children of women who took Paxil during their pregnancy. If you or anyone you know was a victim of Paxil birth defects, contact one of the experienced lawyers at Carey & Danis immediately to discuss a possible case against the manufacturer of the drug, GlaxoSmithKline.

Paxil is in a class of antidepressants known as selective serotonin reuptake inhibitors. This entire class of drugs has recently been under fire from consumer protection groups for its previously undisclosed side effects. However, Paxil has proven itself to be distinguishable for its dangers even amongst a group of harmful SSRIs. For this reason, Carey & Danis has chosen to hold accountable the makers of Paxil, GlaxoSmithKline, for exposing consumers to the dangers inherent in its drug.

The lawyers at Carey & Danis have the experience and the resources to take on the largest corporations in the world. This particular case is no exemption given the enormity of GlaxoSmithKline. It takes lawyers experienced in this type of litigation to tackle a challenge of this magnitude. The lawyers at Carey & Danis have just that. With over $695 million recovered for clients, Carey & Danis is equipped to handle this battle.

The particular risk Paxil poses to infants is known as persistent pulmonary hypertension in the newborn. This condition is rare and affects the heart and lungs of the infant. PPHN inhibits the ability of the infant to breathe properly and can cause damage to other organs as well as the heart and lungs. Furthermore, treatment may not cure PPHN and lasting effects may be experienced by the infant.

If you have experienced any of the side effects associated with Paxil, contact Carey & Danis, we are here to help.